CXCR2 and breast cancer: Overall, these results suggest that CXCR2 inhibition may represent a promising approach to counteract the RT-induced immunosuppressive activity of neutrophils, even if further studies are needed to confirm the trends for a better anti-tumor response observed in the colorectal and breast cancer models.